Which of the following statements regarding ipratropium bromide are true?
1) It is a first-line choice of bronchodilator for chronic obstructive pulmonary disease (COPD) .
2) It can be combined with a agonist for maintenance bronchodilation in COPD.
3) It is added to a agonist in severe asthma episodes that do not respond to a agonist alone.
4) It is a leukotriene modifier used to treat step 3 asthma.
A) 1 and 4 only
B) 2 and 4 only
C) 1,2,and 4 only
D) 1,2,and 3 only
Correct Answer:
Verified
Q10: Which of the following patient populations
Q11: Cholinergic stimulation produces which of the following
Q12: Possible side effects of aerosolized Atrovent include
Q13: Incruse Ellipta is approved for
A)exacerbation of chronic
Q14: Combivent is a combination drug including which
Q16: An anticholinergic that can be administered via
Q17: Ipratropium bromide is indicated to treat which
Q18: The most common side effect of anticholinergic
Q19: Patients using ipratropium aerosols should be instructed
Q20: The combination of albuterol and ipratropium bromide
Unlock this Answer For Free Now!
View this answer and more for free by performing one of the following actions
Scan the QR code to install the App and get 2 free unlocks
Unlock quizzes for free by uploading documents